IP Library Patent Application 16462971
Patent Application
App. No. 16/462,971

TRANSDERMAL DRUG DELIVERY DEVICES AND METHODS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/462,971
Abstract

A system for delivering a drug formulation includes a transdermal membrane, a drug cartridge, and a control unit having a battery, a printed circuit board for actuation of the actuator. The drug cartridge includes a sealed reservoir configured to hold a drug formulation therein, a breaking element configured to break the sealed reservoir upon actuation, and an actuator configured to activate the breaking element to break the sealed reservoir release the drug formulation to the transdermal membrane. The control unit can include a controller configured to activate the actuator at a preset time.

Claims (34)

1 .- 67 . (canceled)

68 . A system for delivering a drug formulation comprising:

a transdermal membrane;

a drug cartridge including:

a sealed reservoir configured to hold a drug formulation therein;

a breaking element configured to break the sealed reservoir upon actuation, and

an actuator configured to activate the breaking element to break the sealed reservoir release the drug formulation to the transdermal membrane; and

a control unit having a battery, a printed circuit board for actuation of the actuator.

69 . The system of claim 68 , further comprising a pressurizing element configured to place pressure on the sealed reservoir such that, upon activation of the breaking element, drug formulation from the sealed reservoir is forced out of the sealed reservoir and onto the transdermal membrane.

70 . The system of claim 68 , further comprising an expandable element connected to the breaking element, wherein, upon actuation by the activator, the expandable element expands to cause the breaking element to break the sealed reservoir and release drug formulation to the transdermal membrane

71 . (canceled)

72 . The system of claim 68 , wherein the drug cartridge and the control unit are separable from one another.

73 . The system of claim 68 , wherein the breaking element is a blade or a needle.

74 . (canceled)

75 . The system of claim 68 , wherein the breaking element is an SMA wire embedded in a portion of the reservoir.

76 . The system of claim 68 , wherein a wall of the reservoir is dissolvable, and wherein the breaking element is a solvent configured to dissolve the wall.

77 . The system of claim 68 , wherein a wall of the reservoir is meltable, and wherein the breaking element is a heater configured to melt the wall.

78 . The system of claim 68 , further comprising a second sealed reservoir configured to hold a drug formulation therein.

79 . The system of claim 78 , further comprising a second breaking element configured to break the second sealed reservoir upon activation.

80 . The system of claim 79 , wherein the system is configured to release drug formulation from the two reservoirs at different times.

81 . The system of claim 68 , wherein the breaking element is configured to pierce the reservoir from a side of the reservoir that is closest to the transdermal membrane.

82 . The system of claim 68 , wherein the actuator includes a fuse wire, a shape memory alloy wire, or a motor and cam

83 . (canceled)

84 . (canceled)

85 . The system of claim 68 , wherein the system has no motor.

86 . The system of claim 68 , wherein the control unit includes a controller configured to activate the actuator at a preset time.

87 . The system of claim 68 , wherein the breaking element is a flat plate configured to crush the reservoir.

88 .- 121 . (canceled)

122 . The system of claim 69 , wherein the pressurizing element is a compressed material.

123 . The system of claim 122 , wherein the compressed material is foam.

124 . The system of claim 69 , wherein the pressurizing element is a plunger.

125 . The system of claim 69 , wherein the pressurizing element is a leaf spring.

126 . The system of claim 69 , wherein the pressurizing element is on a side of the reservoir that is opposite of the transdermal membrane.

127 . The system of claim 126 , wherein the breaking element is configured to pierce the reservoir from a side of the reservoir that is closer to the transdermal membrane than the pressurizing element.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
To: MORNINGSIDE VENTURE INVESTMENTS LIMITED
Reel/Frame 055382/0388 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: CHRONO THERAPEUTICS, INC.
To: CTI (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 055384/0227 →